1Rischin D,Boyer M,Smith J,et al.A phase Ⅰ trial of docetaxel and gemcitabine in patients with advanced cancer[J].Annals of Oncology,2000,11[(4):421-426.
2Miwa M,Ura M,Nishida M,et al.Design of a novel oral fluoropyrimidine carbamate,capecitabine,which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[J].Eur J Cancer,1998,34(8):1274-1281.
3Fossella F, Pereira JR, von Pawel J, et al. Randomized, multinational, phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group [ J ]. J Clin Oncol, 2003,21 (16) :3007 -3008.
4Kubota K,Watanabe K, Kunitoh H,et al. Phase Ⅲ randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage Ⅳ non-small-cell lung cancer: the Japanese Taxotere Lung Cancer study Group [ J ]. J Clin Oncol, 2004,22 (2) :254 -261.
5Spielmann M, Llombart A, Zelek L, et al. Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracyclineresistant advanced breast cancer [ J ]. Ann Oncol, 1999,10 ( 12 ) : 1457 - 1460.
6Marty M,Cognetti F, Maraninchi D,et al. Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2- positive metastatic breast cancer administered as first-line treatment : the M77001 study group [ J ]. J Clin Oncol,2005,23 ( 19 ) : 4265 - 4274.
7Gradishar WJ. Docetaxel as neoadjuvant chemotherapy in patients with stage Ⅲ breast cancer [ J ]. Oncology, 1997,11 (8 Suppl 8) :15 - 18.
